Investor Lists

Biotech investors based in Palo Alto

Updated 7 November 2026

Firms with an address in Palo Alto that we have watched back a biotech company in the last two years.

30investors on the listNo change this week
384cheques in 12 months+4% against the market
$27Mmedian round they joined+231% against the market median
93%wrote a cheque in 12 months
67%have led a round

The Top 25

Ordered by cheques observed, never by anything anyone paid for

Deploying now (24)

  1. 1CRVDeploying nowVC firm · United States588$20Mmedian roundOct 2026last seen
  2. 2VenrockDeploying nowVC firm · United States560$36Mmedian roundOct 2026last seen
  3. 3DCVCDeploying nowVC firm · United States431$29Mmedian roundNov 2026last seen
  4. 4Storm VenturesDeploying nowVC firm · United States262$7Mmedian roundSept 2026last seen
  5. 5Sutter Hill VenturesDeploying nowVC firm · United States217$68Mmedian roundNov 2026last seen
  6. 6AME Cloud VenturesDeploying nowVC firm · United States196$15Mmedian roundSept 2026last seen
  7. 7Innovation EndeavorsDeploying nowVC firm · United States178$18Mmedian roundOct 2026last seen
  8. 8Ulu VenturesDeploying nowVC firm · United States172$7Mmedian roundOct 2026last seen
  9. 9Wing Venture CapitalDeploying nowVC firm · United States163$25Mmedian roundOct 2026last seen
  10. 10UpHonest CapitalDeploying nowVC firm · United States146$5Mmedian roundSept 2026last seen
  11. 11Vivo CapitalDeploying nowPrivate equity · United States140$64Mmedian roundSept 2026last seen
  12. 12Samsara BioCapitalDeploying nowVC firm · United States104$93Mmedian roundNov 2026last seen
  13. 13Acrew CapitalDeploying nowVC firm · United States99$17Mmedian roundNov 2026last seen
  14. 14World Innovation Lab WilDeploying nowVC firm · United States90$21Mmedian roundOct 2026last seen
  15. 15Playground GlobalDeploying nowVC firm · United States86$23Mmedian roundOct 2026last seen
  16. 16Tau VenturesDeploying nowVC firm · United States75$7Mmedian roundOct 2026last seen
  17. 17TCG CrossoverDeploying nowVC firm · United States60$150Mmedian roundOct 2026last seen
  18. 183E BioventuresDeploying nowVC firm · China30$22Mmedian roundMar 2026last seen
  19. 19Emerson CollectiveDeploying nowFamily office · United States27$62Mmedian roundOct 2026last seen
  20. 20Maven VenturesDeploying nowVC firm · United States12$9.6Mmedian roundSept 2026last seen
  21. 21ShangBay CapitalDeploying nowVC firm · United States12$18Mmedian roundApr 2026last seen
  22. 22Gigascale CapitalDeploying nowVC firm · United States11$58Mmedian roundNov 2026last seen
  23. 23LeitmotifDeploying nowVC firm · United States8$155Mmedian roundNov 2026last seen
  24. 24Matter Venture PartnersDeploying nowVC firm · United States8$105Mmedian roundOct 2026last seen
  25. 25Action Potential Venture CapitalquietGrowth equity · United States6$28Mmedian roundAug 2025last seen
5 more on this list

All 30 are in the app, with filters for stage, sector and market. A free account shows 10 per search, Pro up to 1,000.

See the whole list →

Quick answers about biotech investors based in Palo Alto

Who are the most active biotech investors based in Palo Alto?

By cheques observed, the most active are CRV, Venrock, DCVC, Storm Ventures and Sutter Hill Ventures.

How many biotech investors based in Palo Alto are there?

30 are on record. 93% made an investment in the last 12 months and 67% have led a round.

Which stages do biotech investors based in Palo Alto back?

Of the rounds with a named stage in the last 12 months, mostly Series A (33%) and Seed (21%).

How big are the rounds biotech investors based in Palo Alto join?

The typical (median) round among the leading investors here is $23M.

Which sectors do biotech investors based in Palo Alto back most?

In the last 12 months, mostly AI, Biotech and Healthcare.

Which biotech investors based in Palo Alto lead the most rounds?

CRV (19 led), Playground Global (14 led) and DCVC (12 led).

What have biotech investors based in Palo Alto invested in recently?

Recent rounds include Fathom Therapeutics (Nov 2026, with Sutter Hill Ventures), Harbinger (Series D+, Nov 2026, with Leitmotif) and T-Therapeutics (Series B, Nov 2026, with Samsara BioCapital).

How is this list of biotech investors based in Palo Alto ranked?

By cheques observed, from the rounds and filings we watched, and never by anything anyone paid for. It is rebuilt every night.

Built from the rounds we watched, refreshed every night. How we count · Report a correction